According to Edwards Lifesciences's latest financial reports the company has NZ$6.95 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$7.04 B | 173.05% |
2023-12-31 | NZ$2.58 B | 34.88% |
2022-12-31 | NZ$1.91 B | -10.86% |
2021-12-31 | NZ$2.14 B | 10.47% |
2020-12-31 | NZ$1.94 B | -13.69% |
2019-12-31 | NZ$2.25 B | 57.95% |
2018-12-31 | NZ$1.42 B | -24.28% |
2017-12-31 | NZ$1.88 B | 2.63% |
2016-12-31 | NZ$1.83 B | 2.55% |
2015-12-31 | NZ$1.78 B | -2.56% |
2014-12-31 | NZ$1.83 B | 61.07% |
2013-12-31 | NZ$1.14 B | 79.88% |
2012-12-31 | NZ$0.63 B | 9.8% |
2011-12-31 | NZ$0.57 B | 12.43% |
2010-12-31 | NZ$0.51 B | 11.62% |
2009-12-31 | NZ$0.45 B | 17.7% |
2008-12-31 | NZ$0.39 B | 56.57% |
2007-12-31 | NZ$0.24 B | -3.8% |
2006-12-31 | NZ$0.25 B | -0.7% |
2005-12-31 | NZ$0.26 B | 281.29% |
2004-12-31 | NZ$68.53 M | -27.09% |
2003-12-31 | NZ$93.99 M | 43.83% |
2002-12-31 | NZ$65.34 M | -43.11% |
2001-12-31 | NZ$0.11 B | 81.8% |
2000-12-31 | NZ$63.18 M | |
1999-12-31 | N/A |